News
29 February 2024
Extraordinary General Meeting – 15 March 2024, in Malmö, Sweden – Cytovac AB
Fusionsplan...
15 June 2023
Annual General Meeting – 13th of July 2023 – CytoVac AB
Annual General Meeting – 31st of July 2020 in Stockholm, Sweden – CytoVac AB...
31 May 2022
Annual General Meeting – 29th of June 2022 – CytoVac AB
Annual General Meeting – 31st of July 2020 in Stockholm, Sweden – CytoVac AB...
12 July 2021
Extraordinary General Meeting – July 27, 2021 – CytoVac AB
Extraordinary General Meeting – July 27, 2021 – CytoVac AB...
29 April 2021
Annual General Meeting – 28th of May 2021 – CytoVac AB
Annual General Meeting – 28th of May 2021 – CytoVac AB...
30 June 2020
Annual General Meeting – 31st of July 2020 in Stockholm, Sweden – CytoVac AB
Annual General Meeting – 31st of July 2020 in Stockholm, Sweden – CytoVac AB...
14 January 2020
Pressemeddelelse/ Press release 14. jan 2020
Cytovac har igangsat en ny privat kapital rejsning...
10 May 2019
regulatory
Information for investors
During the ongoing IPO process Cytovac has attracted significant institutional demand...
08 April 2019
regulatory
Cytovac presented at Vator Securities Unicorn Summit on the 21st of March 2019
Kim Arvid Nielsen presented Cytovac at the Vator Securities...
08 April 2019
Cytovac represented at Cancer Cluster Salzburg on the 5th of April 2019
Alexei Kirkin was invited to speak ...
26 March 2019
Annual General Meeting – 23rd of April 2019 in Malmö, Sweden – CytoVac AB
Notice of the Annual General Meeting 2019...
12 March 2019
Cytovac presented at Biologics World Nordic 2019 in Stockholm
Karine Dzhandzhugazyan gave a presentation ...
07 March 2018
Publication in Nature Communications
Alexei Kirkin and Karine Dzhandzhugazyan have published an article...